JP2024512215A5 - - Google Patents
Info
- Publication number
- JP2024512215A5 JP2024512215A5 JP2023548242A JP2023548242A JP2024512215A5 JP 2024512215 A5 JP2024512215 A5 JP 2024512215A5 JP 2023548242 A JP2023548242 A JP 2023548242A JP 2023548242 A JP2023548242 A JP 2023548242A JP 2024512215 A5 JP2024512215 A5 JP 2024512215A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- hmpv
- isolated
- residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163148920P | 2021-02-12 | 2021-02-12 | |
| US63/148,920 | 2021-02-12 | ||
| US202163276172P | 2021-11-05 | 2021-11-05 | |
| US63/276,172 | 2021-11-05 | ||
| PCT/US2022/015565 WO2022173714A2 (en) | 2021-02-12 | 2022-02-08 | Antibodies that bind metapneumovirus, antigenic metapneumovirus proteins, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512215A JP2024512215A (ja) | 2024-03-19 |
| JP2024512215A5 true JP2024512215A5 (enExample) | 2025-02-14 |
Family
ID=82838690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548242A Pending JP2024512215A (ja) | 2021-02-12 | 2022-02-08 | メタニューモウイルス、抗原性メタニューモウイルスタンパク質に結合する抗体、及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240327502A1 (enExample) |
| EP (1) | EP4291232A4 (enExample) |
| JP (1) | JP2024512215A (enExample) |
| KR (1) | KR20230146047A (enExample) |
| AU (1) | AU2022220616A1 (enExample) |
| BR (1) | BR112023016241A2 (enExample) |
| CA (1) | CA3208018A1 (enExample) |
| MX (1) | MX2023009447A (enExample) |
| WO (1) | WO2022173714A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025038512A1 (en) * | 2023-08-17 | 2025-02-20 | Merck Sharp & Dohme Llc | Methods for detecting pcr chimeras |
| WO2025097674A1 (zh) * | 2023-11-08 | 2025-05-15 | 安炎达医药技术(广州)有限公司 | 一种新型pace4抑制剂及其在抗骨关节炎中的应用 |
| CN119143871B (zh) * | 2024-11-20 | 2025-02-07 | 首都儿科研究所 | 用于人偏肺病毒检测的单克隆抗体、检测试剂及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040096451A1 (en) * | 2002-07-25 | 2004-05-20 | Young James F. | Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies |
| US7438907B2 (en) * | 2002-11-15 | 2008-10-21 | Genmab A/S | Human monoclonal antibodies against CD25 |
| JP2010505876A (ja) * | 2006-10-04 | 2010-02-25 | ザ スクリプス リサーチ インスティテュート | ヒトメタニューモウイルスを中和するヒト抗体 |
| JP5642972B2 (ja) * | 2007-02-21 | 2014-12-17 | ユニバーシティー オブ マサチューセッツＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ | Ｃ型肝炎ウイルス（ｈｃｖ）に対するヒト抗体およびその使用 |
| EP2445527A2 (en) * | 2009-06-24 | 2012-05-02 | ID Biomedical Corporation of Quebec | Vaccine |
| KR101815265B1 (ko) * | 2013-06-20 | 2018-01-04 | 한올바이오파마주식회사 | FcRn 특이적 인간 항체 및 이를 포함하는 자가면역 질환 치료용 조성물 |
| CA3138550A1 (en) * | 2019-04-30 | 2020-11-05 | Target Discovery Merger Sub II, LLC | Cancer associated antibody compositions and methods of use |
-
2022
- 2022-02-08 JP JP2023548242A patent/JP2024512215A/ja active Pending
- 2022-02-08 MX MX2023009447A patent/MX2023009447A/es unknown
- 2022-02-08 BR BR112023016241A patent/BR112023016241A2/pt unknown
- 2022-02-08 AU AU2022220616A patent/AU2022220616A1/en active Pending
- 2022-02-08 US US18/264,824 patent/US20240327502A1/en active Pending
- 2022-02-08 EP EP22753192.8A patent/EP4291232A4/en active Pending
- 2022-02-08 WO PCT/US2022/015565 patent/WO2022173714A2/en not_active Ceased
- 2022-02-08 KR KR1020237030905A patent/KR20230146047A/ko active Pending
- 2022-02-08 CA CA3208018A patent/CA3208018A1/en active Pending